Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Standard Heparin Dose for Prevention of Forearm Artery Occlusion
NCT02570243Phase 4Completed
- Sponsor
- University of Patras
- Start
- Feb 2015
- Primary completion
- Sep 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of heparin in Radial artery occlusion (RAO) (2 arms), sponsored by University of Patras. Primary endpoint: Radial Artery Occlusion at 30 days. Started Feb 2015; status: completed.
02
Drugs
heparin
03
Conditions
Radial artery occlusion (RAO)
Beyond the preview
Go deeper on NCT02570243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570243.